Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases

Gincy George 1 Lucie-Marie Scailteux 2, 3 Hans Garmo 1 Frédéric Balusson 2 Christopher Cardwell 4 Greet de Coster Harlinde de Schutter Josephina G Kuiper Úna Mcmenamin 4 Julie Verbeeck Mieke van Hemelrijck 1
1 King‘s College London
2 REPERES - Recherche en Pharmaco-épidémiologie et Recours aux Soins
3 CHU Pontchaillou [Rennes]
4 QUB - Queen's University [Belfast]
Keywords : GnRH agonists real world evidence GnRH antagonists cardiovascular disease Prostate cancer
Document type :
Journal articles
Complete list of metadatas

Cited literature [52 references]  Display  Hide  Download
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02055724
Contributor : Laurent Jonchère <>
Submitted on : Wednesday, April 17, 2019 - 9:56:28 AM
Last modification on : Friday, August 23, 2019 - 2:10:25 PM

File

George_et_al-2019-Real‐world...
Publication funded by an institution

Licence

Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

UNIV-RENNES1 | USPC | REPERES | EHESP | UNIV-RENNES | UR1-UFR-SVE

Citation

Gincy George, Lucie-Marie Scailteux, Hans Garmo, Frédéric Balusson, Christopher Cardwell, et al.. Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases. Fundamental and Clinical Pharmacology, Wiley, 2019, 33 (4), pp.479-499. ⟨10.1111/fcp.12454⟩. ⟨hal-02055724⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

38

Files downloads

37